Nutex Health Inc. (NUTX), on Thursday, announced its Board has extended the company's previously authorized $25 million share repurchase program through March 31, 2026.
The repurchases will be scheduled to take effect on or about December 4.
The company said the program is intended to enhance shareholder value and offset dilution from stock compensation tied to under-construction and ramping hospitals.
The buyback plan was originally announced on August 14, for a six-month period beginning after the filing of the company's June-quarter Form 10-Q.
In the pre-market trading, Nutex Health is 2.31% higher at $134.80 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.